Insulin Pen Market is forecasted to surpass US$ 46.9 Bn by 2031
Diabetes is becoming more
common as poor lifestyle choices continue to be prominent around the world. Insulin
pens are a widely used method of treating diabetic individuals. Given this,
Future Market Insights predicts that
insulin pen sales will reach US$ 30,407
million in 2021.
Insulin pens are
used by diabetes patients to avoid problems including cardiovascular diseases
that may arise from this lifestyle-based ailment. To overcome problems related
to conventional methods of insulin administration, insulin pens make the
process easier and faster.
Get More Information on this Report @ https://www.futuremarketinsights.com/reports/insulin-pens-market
According to the WHO,
approximately 1.2 million deaths were caused due to diabetes in 2019 globally.
To reduce the number of deaths or sufferings due to diabetes, the development
of innovative techniques and products for the treatment and maintenance of
diabetes is essential.
Type 2 diabetes cases are
common, but it can be prevented or delayed by a healthy diet, consistent
physical activity, maintaining a standard body weight and avoiding the use of
tobacco. Diabetes can be treated or managed with medicines and regular checking
and treatment. Increasing focus on innovative medical products and research are
increasingly driving a transition towards insulin pen by diabetes patients.
Leading manufacturers in
the insulin
pen market are strengthening their market position through collaborations
with various health and research organizations. Governments in developed and
developing countries are actively taking initiatives to encourage innovative
medical products.
Key Takeaways from
Insulin Pen Services Market Study
- Reusable insulin pens are expected to
account for over 49% the global market share by 2031, supported by a
growing base of environment and cost-conscious consumers.
- Hospital pharmacies will account for
33.8% of the market share in 2031. The soaring influx of patients for
treatment and intensive care support supports growth.
- The U.S. is projected to be the
fastest-growing regional market with a CAGR of 5.6% through 2021-2031
owing to the matured healthcare sector of the country.
- The U.K. and Germany are leading
markets in Europe, accounting for more than 18% and 25% in 2021.
- China is the largest and fastest
growing market in East Asia, exhibiting a 4.7% CAGR through 2031.
- Australia is leading the Oceania
market, accounting for more than 85% of insulin pen revenues in 2021.
Insulin
Pen Market - Key Companies Profiled
- NovoNordisk A/S
- Sanofi
- Eli Lilly
- Diamesco Co., Ltd.
- BigFoot Biomedical, Inc
- Medtronic plc
- Emperra GmbH E-Health Technologies
- YpsoMed AG
- DUKADA Aps
Comments
Post a Comment